Dr. Agrawals Eye Hospital Share Price Today | Stock Price & Dr. Agrawals Eye Hospital Share Screener
As of October 5, 2026, the live Dr. Agrawals Eye Hospital share price (NSE: DRAGARWQ) is ₹5,215.00 on NSE and ₹5,182.10 on BSE, up 1.09% from the previous close, with shares trading between ₹5,162.50 and ₹5,294.00 in today's trading session, and a 52-week range of ₹4,787.85–₹5,422.50. Check Dr. Agrawals Eye Hospital 52-week for the annual price range and momentum. Use the Dr. Agrawals Eye Hospital stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Dr. Agrawals Eye Hospital opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹504 and net income of ₹76, with EBITDA of ₹158, an operating margin of 31.0% and a profit margin of 15.1%.
Dr. Agrawals Eye Hospital Share Price Chart
Track the current stock price of Dr. Agrawals Eye Hospital with an interactive chart. Analyse DRAGARWQ share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Dr. Agrawals Eye Hospital stock quote in one place.
The quote of ₹5,215.00 sits between the 52-week low of ₹4,787.85 and the 52-week high of ₹5,422.50, and the latest session moved 1.09% from the previous close.
Dr. Agrawals Eye Hospital Company Profile - Fundamental Screener
Screen Dr. Agrawals Eye Hospital company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for DRAGARWQ shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare Services sector and the Hospitals industry, and it trades under ISIN INE934C01018.
Company Details
Classification
Identifiers and Leadership
Dr. Agrawals Eye Hospital Balance Sheet Screener
Screen DRAGARWQ balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹767, up from ₹613 in 2025.
Latest statistics put total assets at ₹767 and shareholder funds at ₹346, with a leverage ratio of 1.19.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
Assets |
||||||||||
| Total Assets | 767 | 613 | 496 | 390 | 314 | 155 | 141 | 100 | 81 | 72 |
| Current Assets | 137 | 55 | 60 | 47 | 50 | 44 | 30 | 30 | 23 | 20 |
| Fixed Assets | 403 | 393 | 316 | 260 | 214 | 96 | 94 | 55 | 36 | 33 |
Liabilities |
||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 309 | 317 | 258 | 222 | 183 | 52 | 45 | 19 | 9 | 16 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||||||||
| Total Equity | 346 | 210 | 157 | 113 | 78 | 55 | 56 | 46 | 35 | 29 |
| Share Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves & Surplus | 342 | 205 | 152 | 109 | 74 | 50 | 51 | 41 | 30 | 25 |
Dr. Agrawals Eye Hospital Income Statement Screener - Profit & Revenue Analysis
Screen Dr. Agrawals Eye Hospital income statement and profit fundamentals. Analyze DRAGARWQ quarterly results. Dr. Agrawals Eye Hospital reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For None-None, revenue was ₹504 and net profit was ₹76, equal to earnings per unit of ₹158.80, at an operating margin of 31%.
In that period expenses were ₹345, interest cost ₹11 and tax ₹25. The next period listed, 2026-March, shows revenue of ₹477 and net profit of ₹70.
| Item | None-None | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||||||||
| Revenue | 504 | 477 | 402 | 324 | 270 | 203 | 141 | 179 | 172 | 156 | 150 | 137 | 118 |
| Expenses | 345 | 326 | 279 | 228 | 193 | 144 | 109 | 130 | 141 | 130 | 127 | 120 | 104 |
Operating Costs and Margins | |||||||||||||
| EBITDA | 158 | 151 | 124 | 96 | 77 | 59 | 31 | 49 | 31 | 26 | 23 | 17 | 15 |
| Operating Profit % | 31.00% | 31.00% | 30.00% | 29.00% | 28.00% | 29.00% | 22.00% | 26.00% | 17.00% | 15.00% | 14.00% | 12.00% | 12.00% |
| Depreciation | 47 | 46 | 40 | 27 | 20 | 20 | 19 | 21 | 11 | 10 | 9 | 9 | 6 |
| Interest | 11 | 12 | 13 | 7 | 7 | 6 | 6 | 8 | 3 | 3 | 3 | 4 | 3 |
Profit and Earnings | |||||||||||||
| Profit Before Tax | 102 | 94 | 71 | 62 | 49 | 32 | 6 | 20 | 17 | 13 | 11 | -1 | 5 |
| Tax | 25 | 24 | 16 | 16 | 13 | 8 | 7 | 6 | 6 | 7 | 4 | -1 | 0 |
| Net Profit | 76 | 70 | 55 | 46 | 37 | 24 | -1 | 14 | 12 | 7 | 7 | 0 | 6 |
| EPS | 158.80 | 147.02 | 116.28 | 98.64 | 78.55 | 51.28 | -3.06 | 29.11 | 25.35 | 14.42 | 15.61 | 0.08 | 12.12 |
Dr. Agrawals Eye Hospital Cash Flow Screener - Liquidity Fundamentals
Screen DRAGARWQ cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities generated ₹145, and net cash flow was an outflow of ₹4.
Over the same period, investing activities used ₹174 and financing activities provided ₹25.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||||||
| Operating Activities | 145 | 94 | 90 | 70 | 57 | 34 | 39 | 25 | 19 | 20 |
| Investing Activities | -174 | -133 | -70 | -71 | -46 | -11 | -17 | -25 | -11 | -8 |
Financing and Net Cash | ||||||||||
| Financing Activities | 25 | 17 | -14 | 0 | -4 | -8 | -20 | 2 | -8 | -12 |
| Net Cash Flow | -4 | -23 | 6 | -1 | 7 | 15 | 2 | 2 | -1 | 0 |
Dr. Agrawals Eye Hospital Shareholding Pattern Screener
See Dr. Agrawals Eye Hospital shareholding pattern with promoter, FII, and DII holdings. Check Dr. Agrawals Eye Hospital promoter holding and ownership changes for DRAGARWQ on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 72.67%, foreign institutions 2.20%, domestic institutions 2.12% and the public 17.93%, spread across 24,036 shareholders.
The shareholder count was 24,036 in 2026-Mar, compared with 22,954 in 2026-Jun.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 72.67% | 72.67% | 71.90% | 71.90% | 72.67% | 72.67% | 71.90% | 71.90% |
Institutional Investors | ||||||||
| FII Holding | 2.20% | 2.24% | 1.33% | 1.50% | 1.74% | 1.82% | 0.64% | 0.65% |
| DII Holding | 2.12% | 2.05% | 1.95% | 2.31% | 2.36% | 2.36% | 0.00% | 0.00% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 17.93% | 18.01% | 19.25% | 18.95% | 18.17% | 17.96% | 21.74% | 21.77% |
| Other Holding | 5.07% | 5.03% | 5.57% | 5.34% | 5.06% | 5.19% | 5.72% | 5.69% |
| Shareholder Count | 24,036 | 22,954 | 41,704 | 35,976 | 30,528 | 25,449 | 3,572 | 3,808 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Dr. Agrawals Eye Hospital. Dr. Agrawals Eye Hospital dividend yield can be compared with peers and other stocks in the market.
The latest dividend recorded was ₹7.00 per unit for 2026-March, a yield of 0.14%, compared with ₹6.00 for 2025-March.
Dividends are listed for 10 periods, with the three most recent payouts at ₹7.00, ₹6.00 and ₹2.50 per unit.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹7.00 | 0.14% |
| 2025-March | ₹6.00 | 0.13% |
| 2024-March | ₹2.50 | 0.06% |
| 2023-March | ₹3.00 | 0.10% |
| 2022-March | ₹3.00 | 0.33% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹1.50 | 0.79% |
| 2018-March | ₹1.20 | 0.33% |
| 2017-March | ₹1.50 | 0.25% |
Dr. Agrawals Eye Hospital Stock Index Membership - Nifty & Sensex
See which indices include Dr. Agrawals Eye Hospital stock. Check DRAGARWQ index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Dr. Agrawals Eye Hospital Market Events Screener - Corporate Actions
Get Dr. Agrawals Eye Hospital corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Dr. Agrawals Eye Hospital stock events that may affect DRAGARWQ share price, along with derivatives, futures and options activity and sector gainers.
15 corporate actions are listed, the most recent entry being Annual General Meeting dated September 9, 2026, with a record date of September 9, 2026.
It is followed by Dividend dated September 2, 2026 and Quarterly Result Announcement dated August 3, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-09 | 2026-09-09 | Annual General Meeting | NA | -2.97% |
| 2026-09-02 | 2026-09-02 | Dividend | ₹ 4.00 /share | 3.68% |
| 2026-08-03 | 2026-08-03 | Quarterly Result Announcement | NA | -0.38% |
| 2026-07-02 | 2026-07-02 | Extraordinary General Meeting | NA | 1.66% |
| 2026-05-20 | 2026-05-20 | Quarterly Result Announcement | NA | 0.41% |
| 2026-02-03 | 2026-02-03 | Quarterly Result Announcement | NA | -0.08% |
| 2025-11-07 | 2025-11-07 | Dividend | ₹ 3.00 /share | 2.42% |
| 2025-10-30 | 2025-10-30 | Quarterly Result Announcement | NA | -3.36% |
| 2025-09-24 | 2025-09-24 | Annual General Meeting | NA | -7.76% |
| 2025-09-18 | 2025-09-18 | Dividend | ₹ 3.50 /share | 6.35% |
| 2025-08-12 | 2025-08-12 | Quarterly Result Announcement | NA | 0.71% |
| 2025-05-28 | 2025-05-28 | Quarterly Result Announcement | NA | 2.34% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | -4.87% |
| 2024-11-08 | 2024-11-08 | Dividend | ₹ 2.50 /share | 0.26% |
| 2024-10-29 | 2024-10-29 | Quarterly Result Announcement | NA | -1.55% |
Dr. Agrawals Eye Hospital Competitors Screener - Peer Stocks Comparison
Screen DRAGARWQ competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare Services sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Apollo Hospitals | 114,927 | 53.73 | 25,420 | 15.58% | 2,003 | 30.07 |
| Max Healthcare Institute | 90,732 | 63.12 | 8,536 | 18.82% | 1,442 | 31.81 |
| Aster DM Quality Care | 60,581 | 170.37 | 4,769 | 11.25% | 427 | 33.61 |
| Fortis Healthcare | 58,660 | 55.42 | 9,179 | 16.93% | 1,064 | 24.95 |
| Global Health | 36,107 | 66.12 | 4,509 | 19.56% | 554 | 37.65 |
| Narayana Hrudayalaya | 35,379 | 43.59 | 7,996 | 43.43% | 811 | 33.58 |
| Krishna Institute of Medical Sciences | 30,581 | 158.77 | 3,931 | 28.16% | 242 | 34.97 |
| Dr. Agarwal's Health Care | 15,285 | 83.42 | 2,125 | 20.92% | 168 | 40.98 |
| Rainbow Childrens Medicare | 13,000 | 44.77 | 1,747 | 11.49% | 282 | 21.12 |
| Park Medi World | 11,394 | 39.37 | 1,711 | 19.99% | 274 | 36.47 |
Dr. Agrawals Eye Hospital Company Announcements - News & Reports Screener
Screen DRAGARWQ latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated September 30, 2026.
The next most recent announcements are dated September 10, 2026 and September 9, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-09-30 | Closure of Trading Window | - |
| 2026-09-10 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-09-09 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-08-27 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-08-15 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-14 | 32Nd Annual General Meeting Of The Members Of The Company- September 09 2026 | - |
| 2026-08-14 | Intimation Of Record Date Under Regulation 42 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-08-14 | Reg. 34 (1) Annual Report. | - |
| 2026-08-14 | Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 | - |
| 2026-08-03 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-08-03 | Results- Unaudited Financial Results For The Quarter Ended June 30 2026 | - |
| 2026-08-03 | Board Meeting Outcome for Outcome Of The Board Meeting Held On August 03 2026 | - |
| 2026-07-28 | Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results For The Quarter Ended June 30 2026 | - |
| 2026-07-20 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-07-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-07-02 | Voting Results Of The Honble NCLT Convened Meeting Of The Unsecured Creditors | - |
| 2026-07-02 | Summary Of The Proceedings Of The Honble NCLT Convened Meeting Of The Unsecured Creditors Of Dr. Agarwals Eye Hospital Limited Held On July 02 2026 | - |
| 2026-07-02 | Voting Results Of The Honble NCLT Convened Meeting Of The Secured Creditors | - |
| 2026-07-02 | Summary Of The Proceedings Of The Honble NCLT Convened Meeting Of The Secured Creditors Of Dr. Agarwals Eye Hospital Limited Held On July 02 2026 | - |
| 2026-07-02 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹5,215.00, within a 52-week range of ₹4,787.85 to ₹5,422.50. The P/E ratio is 32.85 and the P/B ratio is 7.23, with earnings per unit of ₹147.02. Market capitalisation stands at ₹2,513.07 Cr and the dividend yield is 0.14%. The company operates in the Healthcare Services sector, in the Hospitals industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 6, 2026. This page covers 10 balance sheet periods, 13 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.